edoc

Items where Author is "Schneider, Sandra"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2011 | 2010
Number of items: 5.

2011

Ruiz, Christian and Holz, David R. and Oeggerli, Martin and Schneider, Sandra and Gonzales, Irma M. and Kiefer, Jeffrey M. and Zellweger, Tobias and Bachmann, Alexander and Koivisto, Pasi A. and Helin, Heikki J. and Mousses, Spyro and Barrett, Michael T. and Azorsa, David O. and Bubendorf, Lukas. (2011) Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer. The journal of pathology, Vol. 223, no. 4. pp. 543-552.

Tapia, Coya and Zlobec, Inti and Schneider, Sandra and Kilic, Ergin and Güth, Uwe and Bubendorf, Lukas and Kim, Suwon. (2011) Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer. Human pathology, Vol. 42, H. 7. pp. 983-990.

Vlajnic, Tatjana and Andreozzi, Maria Carla and Schneider, Sandra and Tornillo, Luigi and Karamitopoulou, Eva and Lugli, Alessandro and Ruiz, Christian and Zlobec, Inti and Terracciano, Luigi. (2011) VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients. Modern pathology, Vol. 24, no. 10. pp. 1404-1412.

2010

Zlobec, Inti and Raineri, Ines and Schneider, Sandra and Schoenegg, René and Grilli, Bruno and Herzog, Michelle and Savic, Spasenija and Bubendorf, Lukas. (2010) Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens. Lung cancer, Vol. 68, H. 2. pp. 192-197.

Pallante, Pierlorenzo and Terracciano, Luigi and Carafa, Vincenza and Schneider, Sandra and Zlobec, Inti and Lugli, Alessandro and Bianco, Mimma and Ferraro, Angelo and Sacchetti, Silvana and Troncone, Giancarlo and Fusco, Alfredo and Tornillo, Luigi. (2010) The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. EJC : European journal of cancer, Vol. 46, H. 12. pp. 2304-2313.

This list was generated on Thu Apr 18 17:38:00 2024 CEST.